MLTX compared with OCUL: revenue, margins and what each company keeps, and the suppliers and customers both name

MLTXMoonLake Immunotherapeutics

Mkt capRevenueRevenue

OCULOcular Therapeutix, Inc

Mkt capRevenueRevenue

Compare

MLTXMoonLake Immunotherapeutics

OCULOcular Therapeutix, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MLTX 1

—Merck Healthcare KGaA, Darmstadt, Germanyunlistedsupplier

Shared 0

No shared counterparties.

Only OCUL 7

—Inceptunlistedsupplier

—Ambulatory surgery centersunlistedcustomer

—Hospital outpatient departmentsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Physicians' officesunlistedcustomer

3 more · OCUL chain ›

MLTXMoonLake Immunotherapeutics

11.47▼−2.64%· post 11.47

Mkt cap$1.0BRevenue—Revenue—

OCULOcular Therapeutix, Inc

6.73▼−3.52%· post 6.73

After hoursNov 2 '26

Mkt cap$1.5BRevenue$13MQ2 FY26Revenue$52MFY25

Compare

After hoursNov 2 '26

MLTXMoonLake Immunotherapeutics

OCULOcular Therapeutix, Inc

11.47▼−2.64%post 11.47

Price

6.73▼−3.52%post 6.73

$1.0B

Mkt cap

$1.5B

—

Revenue

$13MQ2 FY26

—

Revenue

$52MFY25

MLTX11.47▼−2.64%vsOCUL6.73▼−3.52%After hoursNov 2 '26